sulforaphane has been researched along with Anoxemia in 9 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We reported previously that nuclear factor erythroid 2-related factor 2 (Nrf2) and metallothionein (MT) play critical roles in preventing intermittent hypoxia (IH)-induced cardiomyopathy." | 7.88 | Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice. ( Cai, J; Cai, L; Cui, T; Liu, Q; Wang, J; Xin, Y; Yin, X; Zhang, Z; Zheng, Y; Zhou, S, 2018) |
| "Sulforaphane (SFN) is a natural isothiocyanate extracted from cruciferous vegetables with promising anti-inflammatory and anti-oxidative activities." | 5.91 | Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress. ( Cheng, K; Gong, M; Ji, Y; Li, J; Liu, L; Liu, Q; Pan, J; Pei, Y; Sun, J; Tang, Q; Wang, D; Wang, R; Wu, N; Yuan, Y; Zhang, C; Zheng, X, 2023) |
| "Sulforaphane (SFN) is an isothiocyanate (ITC) derived from a glucosinolate, glucoraphinin found in cruciferous vegetables." | 5.72 | Biphasic effect of sulforaphane on angiogenesis in hypoxia ( Bao, Y; Chen, F; Li, D; Liu, S; Tang, M; Wang, P; Wang, Y; Wang, Z; Zhang, Y; Zheng, X, 2022) |
| "Bladder cancer is the fourth common cancer among men and more than 70% of the bladder cancer is nonmuscle invasive bladder cancer (NMIBC)." | 5.51 | Sulforaphane Inhibits Nonmuscle Invasive Bladder Cancer Cells Proliferation through Suppression of HIF-1α-Mediated Glycolysis in Hypoxia. ( Jung, YD; Kang, TW; Lian, S; Xia, Y; Zhang, C, 2019) |
| "In this study, C57BL/6 J mice were administrated with an Nrf2 activator, sulforaphane (SFN) before taking incremental treadmill exercise to exhaustion under hypoxia; then the effects of SFN on exercise endurance and molecular/biochemical makers of the skeletal muscle were evaluated." | 3.96 | Nrf2 Activation Enhances Muscular MCT1 Expression and Hypoxic Exercise Capacity. ( Wang, J; Wang, L; Yu, S; Zhang, Y; Zhu, R, 2020) |
| "We reported previously that nuclear factor erythroid 2-related factor 2 (Nrf2) and metallothionein (MT) play critical roles in preventing intermittent hypoxia (IH)-induced cardiomyopathy." | 3.88 | Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice. ( Cai, J; Cai, L; Cui, T; Liu, Q; Wang, J; Xin, Y; Yin, X; Zhang, Z; Zheng, Y; Zhou, S, 2018) |
| "Sulforaphane (SFN) is a natural isothiocyanate extracted from cruciferous vegetables with promising anti-inflammatory and anti-oxidative activities." | 1.91 | Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress. ( Cheng, K; Gong, M; Ji, Y; Li, J; Liu, L; Liu, Q; Pan, J; Pei, Y; Sun, J; Tang, Q; Wang, D; Wang, R; Wu, N; Yuan, Y; Zhang, C; Zheng, X, 2023) |
| "Sulforaphane (SFN) is an isothiocyanate (ITC) derived from a glucosinolate, glucoraphinin found in cruciferous vegetables." | 1.72 | Biphasic effect of sulforaphane on angiogenesis in hypoxia ( Bao, Y; Chen, F; Li, D; Liu, S; Tang, M; Wang, P; Wang, Y; Wang, Z; Zhang, Y; Zheng, X, 2022) |
| "Bladder cancer is the fourth common cancer among men and more than 70% of the bladder cancer is nonmuscle invasive bladder cancer (NMIBC)." | 1.51 | Sulforaphane Inhibits Nonmuscle Invasive Bladder Cancer Cells Proliferation through Suppression of HIF-1α-Mediated Glycolysis in Hypoxia. ( Jung, YD; Kang, TW; Lian, S; Xia, Y; Zhang, C, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Chen, F | 1 |
| Zhang, Y | 2 |
| Zheng, X | 2 |
| Liu, S | 1 |
| Tang, M | 1 |
| Wang, Z | 1 |
| Wang, P | 1 |
| Bao, Y | 1 |
| Li, D | 1 |
| Kapoor, S | 1 |
| Kala, D | 1 |
| Svoboda, J | 1 |
| Daněk, J | 1 |
| Faridová, A | 1 |
| Brnoliaková, Z | 1 |
| Mikulecká, A | 1 |
| Folbergrová, J | 1 |
| Otáhal, J | 1 |
| Zhang, X | 1 |
| Chen, Y | 1 |
| Li, H | 1 |
| Chen, B | 1 |
| Liu, Z | 1 |
| Wu, G | 1 |
| Li, C | 1 |
| Li, R | 1 |
| Cao, Y | 1 |
| Zhou, J | 1 |
| Shen, M | 1 |
| Liu, H | 1 |
| Tao, J | 1 |
| Pan, J | 1 |
| Wang, R | 1 |
| Pei, Y | 1 |
| Wang, D | 1 |
| Wu, N | 1 |
| Ji, Y | 1 |
| Tang, Q | 1 |
| Liu, L | 1 |
| Cheng, K | 1 |
| Liu, Q | 2 |
| Sun, J | 1 |
| Gong, M | 1 |
| Li, J | 1 |
| Zhang, C | 2 |
| Yuan, Y | 1 |
| Wang, L | 1 |
| Zhu, R | 1 |
| Wang, J | 3 |
| Yu, S | 1 |
| Warpsinski, G | 1 |
| Smith, MJ | 1 |
| Srivastava, S | 1 |
| Keeley, TP | 1 |
| Siow, RCM | 1 |
| Fraser, PA | 1 |
| Mann, GE | 1 |
| Zhou, S | 1 |
| Yin, X | 1 |
| Xin, Y | 1 |
| Zhang, Z | 1 |
| Cui, T | 1 |
| Cai, J | 1 |
| Zheng, Y | 1 |
| Cai, L | 1 |
| Xia, Y | 1 |
| Kang, TW | 1 |
| Jung, YD | 1 |
| Lian, S | 1 |
| Bertl, E | 1 |
| Bartsch, H | 1 |
| Gerhäuser, C | 1 |
9 other studies available for sulforaphane and Anoxemia
| Article | Year |
|---|---|
Biphasic effect of sulforaphane on angiogenesis in hypoxia
Topics: Apoptosis; Functional Food; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia; Isothiocyanates | 2022 |
The effect of sulforaphane on perinatal hypoxic-ischemic brain injury in rats.
Topics: Animals; Animals, Newborn; Brain; Brain Injuries; Fluorodeoxyglucose F18; Glucose; Hypoxia; Hypoxia- | 2022 |
Sulforaphane Acts Through NFE2L2 to Prevent Hypoxia-Induced Apoptosis in Porcine Granulosa Cells via Activating Antioxidant Defenses and Mitophagy.
Topics: Animals; Antioxidants; Apoptosis; Female; Granulosa Cells; Hypoxia; Isothiocyanates; Mammals; Mitoph | 2022 |
Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress.
Topics: Animals; Cell Proliferation; Endothelial Cells; Hypertension, Pulmonary; Hypoxia; Inflammation; Isot | 2023 |
Nrf2 Activation Enhances Muscular MCT1 Expression and Hypoxic Exercise Capacity.
Topics: Activating Transcription Factor 3; Animals; Basigin; Energy Metabolism; Hypoxia; Hypoxia-Inducible F | 2020 |
Nrf2-regulated redox signaling in brain endothelial cells adapted to physiological oxygen levels: Consequences for sulforaphane mediated protection against hypoxia-reoxygenation.
Topics: Animals; Brain; Endothelial Cells; Humans; Hypoxia; Isothiocyanates; Kelch-Like ECH-Associated Prote | 2020 |
Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Gene Expression Regulation; Hypoxia; Isothiocyanates; | 2018 |
Sulforaphane Inhibits Nonmuscle Invasive Bladder Cancer Cells Proliferation through Suppression of HIF-1α-Mediated Glycolysis in Hypoxia.
Topics: Cell Line, Tumor; Cell Proliferation; Glycolysis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha | 2019 |
Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Basement Membrane; Cell Line; Cell Proliferation; | 2006 |